izpis_h1_title_alt

Načrtovanje, sinteza in vrednotenje naftalenskih zaviralcev Hsp90 s triazolnim skeletom
ID Lavrič, Jure (Avtor), ID Tomašič, Tihomir (Mentor) Več o mentorju... Povezava se odpre v novem oknu, ID Dernovšek, Jaka (Komentor)

.pdfPDF - Predstavitvena datoteka, prenos (2,11 MB)
MD5: FFBE963E6B2B71C0D42D38BD9660B3DB

Izvleček
Proteini toplotnega šoka (Hsp) ali stresni proteini so evolucijsko ohranjena družina šaperonov, ki s preprečevanjem agregacije in zagotavljanjem pravilnega zvijanja proteinov pomagajo ohranjati celično proteostazo. Njihovo izražanje je povečano pod stresnimi pogoji, tako v zdravih kot tudi v rakavih celicah. V slednjih so proteini toplotnega šoka, med njimi tudi Hsp90, še posebej pomembni, saj so mnogi onkogeni proteini, ki so potrebni za proliferacijo rakavih celic, nestabilni in nepravilno zviti. Zaviranje Hsp90 je zato izredno zanimiv pristop v terapiji rakavih obolenj. Prvi zaviralci Hsp90 so se vezali v N-končno domeno Hsp90 in s tem zavirali ATP-azno aktivnost. Posledica takšnega mehanizma zaviranja Hsp90 je bila sočasna indukcija odziva toplotnega šoka, ki je povečal izražanje genov za sintezo proteinov toplotnega šoka, celica pa je s tem postala odporna na terapijo pri istem odmerku. Ob povečevanju odmerka so se pojavili neželeni učinki, kar je bil povod za razvoj zaviralcev C-končne domene Hsp90, ki ne inducirajo odziva toplotnega šoka. V sklopu magistrske naloge smo zato pripravili dvanajst različnih zaviralcev na osnovi 1,2,3-triazolnega skeleta, ki se vežejo v C-končno domeno Hsp90. Vse spojine vsebujejo triazolno ogrodje in 7-metoksi substituiran naftalen, razlikujejo pa se po orientaciji amidne skupine in bazičnem centru ter distančniku, ki ju loči. Spojine smo razdelili v dve knjižnici, A in B, glede na prostorsko orientacijo amidne skupine, saj smo želeli določiti, kako ta sprememba vpliva na zaviralno aktivnost spojin. Končne spojine smo biološko ovrednotili s testom MTS na celični liniji raka dojke MCF-7. Rezultate smo podali kot srednjo zaviralno koncentracijo (IC50). Za primerjavo smo testirali predhodno sintetizirano spojino TJD-163. Izmed pripravljenih zaviralcev le spojina 11 ni izkazovala aktivnosti, kar pripisujemo dolgemu in fleksibilnemu distančniku med amidno skupino in bazičnim centrom. Spojini z najmočnejšo zaviralno aktivnostjo sta bili 25 (2,4 ± 0,1 μM) in 13 (2,8 ± 0,6 μM). S primerjavo ostalih rezultatov smo ugotovili, da je za učinkovito antiproliferativno delovanje najpomembnejša razdalja med naftalenskim obročem in kationskim centrom. Delovanje pa ojačata tudi nižja stopnja substitucije amina (1° > 2° ⡈ 3°) in prisotnost bazičnega centra (N > O), medtem ko lahko na aktivnost v manjši meri vpliva tudi orientacija amida. Dobljeni rezultati tako nudijo dragocen vpogled k razumevanju povezave med strukturo spojin in njihovim antiproliferativnim delovanjem.

Jezik:Slovenski jezik
Ključne besede:Rak, Hsp90, triazol, zaviralec, SAR
Vrsta gradiva:Magistrsko delo/naloga
Organizacija:FFA - Fakulteta za farmacijo
Leto izida:2023
PID:20.500.12556/RUL-147208 Povezava se odpre v novem oknu
Datum objave v RUL:25.06.2023
Število ogledov:299
Število prenosov:102
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Design, synthesis and evaluation of naphthalene-based Hsp90 inhibitors with triazole scaffold
Izvleček:
Heat shock proteins (Hsp) or stress proteins are an evolutionarily conserved family of chaperones that contribute to the maintenance of cellular proteostasis by preventing aggregation and ensuring the correct folding of proteins. Their expression is increased under stress conditions, both in healthy and cancerous cells. In the latter, heat shock proteins, including Hsp90, are particularly important because many oncogenic proteins necessary for cancer cell proliferation are unstable and misfolded. Inhibition of Hsp90 therefore has a therapeutic benefit for cancer therapy. The first Hsp90 inhibitors bound to the N-terminal domain of Hsp90 and thus inhibited ATPase activity. Such a mechanism of Hsp90 inhibition led to a concomitant induction of the heat shock response, which increased the expression of genes for heat shock protein synthesis, making the cell resistant to therapy at the same dose. When the dose was increased, adverse effects occurred, leading to the development of inhibitors of the C-terminal domain of Hsp90 that do not induce the heat shock response. In this Master's thesis, we therefore prepared 12 different inhibitors based on the 1,2,3-triazole ring that bind to the Hsp90 C-terminal domain. All compounds contain a triazole ring and 7-methoxy-substituted naphthalene moiety and differ in the orientation of the amide group as well as the basic centre and spacer separating them. We divided the compounds into libraries A and B according to the spatial orientation of the amide group, as we wanted to determine how the change in orientation affected the inhibitory activity of the compounds. The final compounds were biologically assessed using the MTS assay in the MCF-7 breast cancer cell line. The results are reported as the mean inhibitory concentration (IC50). For comparison, we tested the previously synthesised compound TJD-163. Of the inhibitors prepared, only compound 11 showed no activity, which may be attributed to the long and flexible spacer between the amide group and the basic centre. The compounds with the strongest inhibitory activity were 25 (2.4 ± 0.1 μM) and 13 (2.8 ± 0.6 μM). Comparing the other results, we found that the distance between the naphthalene ring and the cationic centre is most important for effective antiproliferative activity. The activity is also enhanced by a lower degree of amine substitution (1° > 2° ⡈ 3°) and the presence of a basic centre (N > O), while the activity can also be influenced to a lesser extent by the orientation of the amide bond. The results obtained thus provide valuable insights into understanding the relationship between the structure of the compounds and their antiproliferative activity.

Ključne besede:Cancer, Hsp90, triazole, inhibitor, SAR

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj